Topic · page 25 of 119

Type 2 & other diabetes

Type 2 diabetes and prediabetes: prevention, remission, glucose-lowering drugs, weight-based treatment, insulin, lifestyle and diet; monogenic and other specific types of diabetes

Briefs 961–1,000 of 4,758 placed here, newest publication first

Briefs in Type 2 & other diabetes

Newest publication first

Cardiovasc Diabetol29 Dec 2025
SCORE2-diabetes for predicting coronary artery disease: a cardiac CT study in a diabetic moderate-risk region population
Cohort study
Cardiovasc Diabetol29 Dec 2025
Sirtuins and regulatory miRNAs as epigenetic determinants of empagliflozin-mediated recovery after acute myocardial infarction
Mechanistic study
Diabetes Res Clin Pract29 Dec 2025
Acute hypoglycemia attenuates serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in type 2 diabetes
Cohort study
Nat Med29 Dec 2025
The global macroeconomic burden of diabetes mellitus
Research article
BMJ Open Diabetes Res Care29 Dec 2025
Metal Mixture Inflammatory Index and diabetes risk in US adults: a cross-sectional analysis of NHANES 1999–2020 and development of a LASSO-based prediction model
Cross-sectional study
Cardiovasc Diabetol28 Dec 2025
The effect of exercise characteristics on HbA1c and other cardiovascular risk factors in adults with type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials
Meta-analysis
Diabetes Obes Metab28 Dec 2025
Comparative effectiveness of glucose monitoring methods and glycaemic control in patients with type 2 diabetes: An umbrella review
Randomized controlled trial
Diabetes Obes Metab28 Dec 2025
Effects of SGLT2 inhibitors on development and progression of kidney disease in Chinese patients with type 2 diabetes: A multicentre, prospective real‐world study
Cohort study
Obesity (Silver Spring)26 Dec 2025
Weight Loss With SGLT2 Inhibitors, Semaglutide, and Transcranial Magnetic Stimulation in Type 2 Diabetes and Obesity
Cohort study
Cardiovasc Diabetol25 Dec 2025
Distinct compositional alterations in plasma lipoproteins in type 2 diabetes: a cross-sectional study of healthy individuals and diabetics with and without cardiovascular comorbidities
Cross-sectional study
Diabetes Obes Metab25 Dec 2025
Comprehensive risk factor control and its biomarker‐mediated association with diabetic microvascular complications
Cohort study
Diabet Med25 Dec 2025
Relationship between patient activation, experienced stigma, and internalised weight stigma in people with type 2 diabetes
Cross-sectional study
Cardiovasc Diabetol24 Dec 2025
Improved sex-specific cardiovascular risk prediction with multi-omics data in people with type 2 diabetes
Diagnostic or prognostic study
Cardiovasc Diabetol24 Dec 2025
Cardiovascular outcomes associated with incident diabetes during statin therapy: a nationwide propensity-matched cohort study
Cohort study
Cardiovasc Diabetol24 Dec 2025
Glucagon-like peptide-1 receptor agonists and risk for cardiovascular events in older adults treated with levothyroxine: a target trial emulation
Cohort study
Diabetologia24 Dec 2025
Effects of insulin regimens for type 2 diabetes mellitus: a systematic review and network meta-analysis
Meta-analysis
Diabetes Res Clin Pract24 Dec 2025
GLP-1 receptor agonist use during immune checkpoint inhibitor therapy is associated with mortality and Immune-Related adverse events across cancer types in People with type 2 Diabetes: A Target-Trial emulation
Cohort study
J Clin Endocrinol Metab24 Dec 2025
Sustained Action of Imapextide, A Glucagon-Like Peptide-1 Receptor Antagonist, in Healthy Volunteers
Randomized controlled trial
Diabetes Res Clin Pract23 Dec 2025
Major adverse cardiovascular and limb events caused by tirzepatide in patients with type 2 diabetes at high cardiovascular risk: A comparison with sitagliptin
Cohort study
Diabetes Care23 Dec 2025
Differential Longitudinal Effects of Glucose-Lowering Medications on Glucagon and C-peptide Responses in the Glycemia Reduction Approaches in Diabetes: A Comparative Effectiveness Study (GRADE)
Secondary analysis
Eur J Endocrinol23 Dec 2025
Pharmacodynamics of vicadrostat for aldosterone synthase inhibition in patients with CKD
Secondary analysis
Diabetes Res Clin Pract22 Dec 2025
Metformin and all-cause mortality in older adults with type 2 diabetes mellitus and hypertension: NHANES 1999–2018 evidence for albumin as a mediator
Cohort study
Diabetes Obes Metab22 Dec 2025
Association between glucagon‐like peptide‐1 receptor agonists and risk of dementia in older adults with type 2 diabetes: A target trial emulation
Cohort study
Diabetes Res Clin Pract22 Dec 2025
Economic evaluation of NT-proBNP for heart failure risk assessment in patients with type 2 diabetes in China
Research article
Cardiovasc Diabetol22 Dec 2025
Very long-chain saturated fatty acids in plasma lipids: association with cardiometabolic risk influenced by lipid interactions
Cohort study
Diabetes Res Clin Pract21 Dec 2025
Can a consumer-grade bioimpedance device accurately estimate sarcopenia in women with type 2 diabetes? A cross-sectional agreement study with dual-energy X-ray absorptiometry
Diagnostic or prognostic study
Diabetologia21 Dec 2025
Prevalence of type 2 diabetes among global Indigenous adult populations: a systematic review
Meta-analysis
Diabetes Res Clin Pract20 Dec 2025
Comparative effectiveness of telehealth-delivered family and standard models of diabetes self-management education and support for persons with type 2 diabetes mellitus
Randomized controlled trial
Cardiovasc Diabetol20 Dec 2025
Once-weekly semaglutide versus placebo for the treatment of type 2 diabetes and chronic kidney disease in Denmark: A long-term cost-effectiveness analysis based on FLOW
Research article
Diabetologia19 Dec 2025
Efficacy of tirzepatide versus semaglutide in achieving therapeutic targets in type 2 diabetes: a post hoc analysis of the SURPASS-2 Trial
Secondary analysis
Diabetologia19 Dec 2025
Effects of combined intraduodenal administration of lauric acid and l-tryptophan on postprandial plasma glucose, glucoregulatory hormones and gastric emptying in type 2 diabetes: a double-blind, randomised, crossover study
Randomized controlled trial
Diabetes Obes Metab19 Dec 2025
Efficacy of a low‐carbohydrate diet combined with exercise on glycemic control and metabolic health in type 2 diabetes mellitus: A systematic review and meta‐analysis
Meta-analysis
Diabetes Obes Metab19 Dec 2025
Efficacy and safety of combining empagliflozin in people with type 2 diabetes mellitus uncontrolled with metformin and sitagliptin: A randomised, double‐blind, multicentre, therapeutic confirmatory phase 3 clinical trial
Randomized controlled trial
Diabetes Res Clin Pract18 Dec 2025
A phase 1b, randomized, open-label study of once-weekly insulin GZR4 in patients with type 2 diabetes mellitus
Randomized controlled trial
Cardiovasc Diabetol17 Dec 2025
Arterial collagen IV and laminin levels associate with type 2 diabetes, glycemic control, major adverse cardiac events, and mortality in coronary bypass patients
Cohort study
Diabetes Obes Metab17 Dec 2025
Glucose tolerance and mortality across 24 cancer types and stages: A K‐ CURE Nationwide registry study
Cohort study
Diabetes Obes Metab17 Dec 2025
Serum glycated albumin‐to‐albumin ratio and mortality risk in cardiovascular–kidney–metabolic syndrome: Evidence from NHANES over 15 years
Cohort study
Endocr Pract17 Dec 2025
A Meta-Analysis of Body Composition Changes Associated With Long-term Use of Sodium–Glucose Cotransporter 2 Inhibitors
Meta-analysis
Endocr Pract17 Dec 2025
Antidiabetic Medications and Bladder Cancer Risk in Type 2 Diabetes: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Meta-analysis
Cardiovasc Diabetol16 Dec 2025
Myocardial interstitial fibrosis and subclinical left ventricular systolic dysfunction in type 2 diabetes mellitus patients with obesity: a 3.0 T MRI study
Cross-sectional study

All 4,758 Briefs in ExploreShowing Briefs 961–1,000 of 4,758, newest first